These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20190514)

  • 1. [Pharmacological properties of novel TRPC channel inhibitors].
    Kiyonaka S; Kato K; Nishida M; Mori Y
    Yakugaku Zasshi; 2010 Mar; 130(3):303-11. PubMed ID: 20190514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound.
    Kiyonaka S; Kato K; Nishida M; Mio K; Numaga T; Sawaguchi Y; Yoshida T; Wakamori M; Mori E; Numata T; Ishii M; Takemoto H; Ojida A; Watanabe K; Uemura A; Kurose H; Morii T; Kobayashi T; Sato Y; Sato C; Hamachi I; Mori Y
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5400-5. PubMed ID: 19289841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
    Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
    J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.
    Koenig S; Schernthaner M; Maechler H; Kappe CO; Glasnov TN; Hoefler G; Braune M; Wittchow E; Groschner K
    J Pharmacol Exp Ther; 2013 Jan; 344(1):33-40. PubMed ID: 23010361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].
    Nishida M; Watanabe K; Nakaya M; Kurose H
    Yakugaku Zasshi; 2010 Mar; 130(3):295-302. PubMed ID: 20190513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Selective TRPC3 Inhibitor Pyr3 Attenuates Myocardial Ischemia/Reperfusion Injury in Mice.
    Lu M; Fang XX; Shi DD; Liu R; Ding Y; Zhang QF; Wang HQ; Tang JM; He XJ
    Curr Med Sci; 2020 Dec; 40(6):1107-1113. PubMed ID: 33428139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways.
    Schleifer H; Doleschal B; Lichtenegger M; Oppenrieder R; Derler I; Frischauf I; Glasnov TN; Kappe CO; Romanin C; Groschner K
    Br J Pharmacol; 2012 Dec; 167(8):1712-22. PubMed ID: 22862290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity.
    Kim MS; Lee KP; Yang D; Shin DM; Abramowitz J; Kiyonaka S; Birnbaumer L; Mori Y; Muallem S
    Gastroenterology; 2011 Jun; 140(7):2107-15, 2115.e1-4. PubMed ID: 21354153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells.
    Chen Y; Yan Q; Zhou P; Li S; Zhu F
    J Neurovirol; 2019 Feb; 25(1):101-113. PubMed ID: 30397826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
    Abdoul-Azize S; Buquet C; Vannier JP; Dubus I
    Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPC3 channel contributes to nitric oxide release: significance during normoxia and hypoxia-reoxygenation.
    Huang JH; He GW; Xue HM; Yao XQ; Liu XC; Underwood MJ; Yang Q
    Cardiovasc Res; 2011 Aug; 91(3):472-82. PubMed ID: 21493700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
    Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
    Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FKBP52 regulates TRPC3-dependent Ca
    Bandleon S; Strunz PP; Pickel S; Tiapko O; Cellini A; Miranda-Laferte E; Eder-Negrin P
    J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31540954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proarrhythmic effect of sustained EPAC activation on TRPC3/4 in rat ventricular cardiomyocytes.
    Domínguez-Rodríguez A; Ruiz-Hurtado G; Sabourin J; Gómez AM; Alvarez JL; Benitah JP
    J Mol Cell Cardiol; 2015 Oct; 87():74-8. PubMed ID: 26219954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiological significance of the canonical transient receptor potential (TRPC) subfamily in astrocyte activation].
    Shirakawa H
    Yakugaku Zasshi; 2012; 132(5):587-93. PubMed ID: 22687694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway.
    Louhivuori LM; Jansson L; Nordström T; Bart G; Näsman J; Akerman KE
    Cell Calcium; 2010; 48(2-3):114-23. PubMed ID: 20728215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical transient receptor potential 3 channels activate NF-κB to mediate allergic airway disease via PKC-α/IκB-α and calcineurin/IκB-β pathways.
    Song T; Zheng YM; Vincent PA; Cai D; Rosenberg P; Wang YX
    FASEB J; 2016 Jan; 30(1):214-29. PubMed ID: 26373801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Receptor Potential Channel Canonical Type 3 Deficiency Antagonizes Myofibroblast Transdifferentiation In Vivo.
    Xia W; Wang Q; Lu Y; Hu Y; Zhang X; Zhang J; Liu D; Song J; Zhu Z; Liu D; Zhang H
    Biomed Res Int; 2020; 2020():1202189. PubMed ID: 32219126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.